• Blog
  • Hospital Acquired Pneumonia Prevention Market Report

    Hospital Acquired Pneumonia Prevention Market Report

    Hospital Acquired Pneumonia Prevention Market Report
    Report code - SR1515 Delivery - 2 Weeks
    Get Free Sample |
    Hospital-Acquired Pneumonia Prevention Market Trends, Dynamics & Market Insights
    See more...

    Impact of COVID-19 on Hospital Acquired Pneumonia Prevention Market

    Covid-19 has impacted the market dynamics, competition, and global...

    See more...

    Impact of COVID-19 on Hospital Acquired Pneumonia Prevention Market

    Covid-19 has impacted the market dynamics, competition, and global supply chain. The revenues have gone down in 2020 and may resume an uptrend gradually from 2021. Companies optimizing their operation and strategy will sustain and beat the competition.

    Note: The summary below might not have included insights on covid impact since we have large number of reports.

    Market Insights

    The Hospital-Acquired Pneumonia Prevention market is projected to grow from USD xx million in 2020 to USD xx million by 2026 at a CAGR of around xx% during the forecast period.

    Figure: Hospital-Acquired Pneumonia Prevention Market Size, 2020-2026 (USD Million)

    Hospital-Acquired-Pneumonia-Prevention-Market-Forecast

    Wish to get a free sample? Register Here

    What is hospital-acquired pneumonia?

    Hospital-Acquired Pneumonia (HAP) is defined as a lower respiratory infection that does not incubate at the time of hospital admission but presents clinically for two or more days after hospitalization. Incidence of HAP is highly prevalent in the medical and surgical Intensive Care Units, and results in an additional cost to the healthcare centers and increases the length of stay in ICU.

    Key Players

    Key players operating in the hospital-acquired pneumonia prevention market are-

    • Halyard Health, Inc. (US)
    • Intersurgical Ltd. (UK)
    • Medline Industries, Inc. (US)
    • Sage Products LLC (Stryker Corporation) (US).

    Market Dynamics

    With an expanding geriatric population across the globe, the immunity level is observed to fall significantly. These two factors are expected to collectively propel the need for hospital-acquired pneumonia prevention in the next few years. Moreover, the rising prevalence of chronic diseases along with lengthy hospital stay duration will also escalate the chances of acquiring infections such as pneumonia, eventually pushing the demand for prevention of hospital-acquired pneumonia, thus bolstering the industry growth.

    Segments' Analysis

    End-Use Trends

    By end-use, the hospital-acquired pneumonia prevention market has been classified into hospitals, rehabilitation centers, and home care settings. Under these, the hospital's segment accounted for a significant market share in 2020 and is projected to register significant growth during the review period. Several patients who remain hospitalized for a long duration are suffering from pneumonia. Hence, the risk of acquiring pneumonia for a healthy person is much greater across hospitals and healthcare centers, which fosters the segment growth.

    Regional Trends

    By region, the market in North America accounted for the largest market share in 2020 and is projected to grow at a significant CAGR during the assessment period. This is mainly ascribed presence of a large number of hospitals, stringent sterilization, and sanitary activities in the region, presence of well-established healthcare infrastructure, and advancements in the field of hospital hygiene and care, which further proliferates the regional market growth.

    COVID-19 Impact on Hospital-Acquired Pneumonia Prevention Market

    The COVID-19 outbreak positively influenced the hospital-acquired pneumonia prevention market growth. The pandemic resulted in a soaring number of affected patients across the globe, which put a strain on the healthcare sector. To prevent the spread of infection, there was a strong need for hospital-acquired pneumonia prevention amid the pandemic.

    Critical Questions Answered in the Report

    • What are the key trends in the hospital-acquired pneumonia prevention market?
    • How the market (and its various sub-segments) has grown in the last five years and what would be the growth rate in the next five years?
    • What is the impact of COVID-19 on the hospital-acquired pneumonia prevention market?
    • What are the key strategies adopted by the major vendors to lead in the global hospital-acquired pneumonia prevention market?
    • What is the market share of the top vendors?

    Get the full scope of the report. Register Here

    Target Audience

    Here is the list of the group of customers that the hospital-aquired pneumonia prevention market hopes to have the greatest opportunity to convert-

    • Hospital-Acquired Pneumonia Prevention distributors
    • Hospital-Acquired Pneumonia Prevention suppliers
    • Hospital-Acquired Pneumonia Prevention manufacturers
    • Logistics organizations
    • Government bodies

    Custom Research: Stratview research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry at sales@stratviewresearch.com.

    Frequently Asked Questions (FAQs)

    Halyard Health, Inc. (US), Intersurgical Ltd. (UK), Medline Industries, Inc. (US), and Sage Prod-ucts LLC (Stryker Corporation) (US) are among the key players in the hospital-acquired pneumonia prevention market.

    Expanding geriatric population across the globe, the rising prevalence of chronic diseases along with lengthy hospital stay duration are the factors driving the growth of hospital-acquired pneumonia prevention market.

    The hospital's segment is expected to register a significant growth in the hospital-acquired pneumonia prevention market.

    North America accounted for the largest share in the hospital-acquired pneumonia prevention market in 2020.

    Hospital-Acquired Pneumonia Prevention distributors, Hospital-Acquired Pneumonia Prevention suppliers, Hospital-Acquired Pneumonia Prevention manufacturers, Logistics organizations, Government bodies are the target audience in the hospital-acquired pneumonia prevention market.

    //